Ranbaxy Pharmaceuticals Inc. Exits from Chinese Joint Venture with Ranbaxy Ghuangzhou China; Sells Stake to HNG Chembio Pharmacy Co Ltd

Published: Dec 29, 2009

Bookmark and Share

Financialexpress.com -- Ranbaxy Laboratories said it has sold its entire stake in Chinese joint venture, Ranbaxy Ghuangzhou China, to HNG Chembio Pharmacy Co Ltd for an undisclosed amount. Ranbaxy Ghuangzhou China (RGCL) is a joint venture formed in 1993 between the Ranbaxy group, Guangzhou Baiyunshan Pharmaceutical Company Ltd, China and Hong Kong New Chemic.

Back to news